Who is sponsoring NCT07333625?

NCT07333625 is sponsored by Universitas Noor Huda Mustofa.

What drugs are being tested in NCT07333625?

Interventions in NCT07333625: Spiritual Care Program, Standard Diabetes Care.

What condition does NCT07333625 study?

NCT07333625 studies Type 2 Diabetes Mellitus (T2DM).

Is NCT07333625 still recruiting?

NCT07333625 is currently completed. Last updated 12 January 2026.

Last reviewed 2026-01-12 · How we verify

NCT07333625: SC-DMT2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Spiritual Care for Psychological and Glycemic Outcomes in Type 2 Diabetes

Completed NA Last updated 12 January 2026

What this trial tests

NA trial testing Spiritual Care Program in Type 2 Diabetes Mellitus (T2DM) in 80 participants. Completed in 5 July 2024.

Timeline

2 June 2024

Primary endpoint
5 June 2024

5 July 2024

Quick facts

Lead sponsor	Universitas Noor Huda Mustofa
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	80
Start date	2 June 2024
Primary completion	5 June 2024
Estimated completion	5 July 2024
Sites	1 location across Indonesia

Drugs / interventions tested

Spiritual Care Program
Standard Diabetes Care

Conditions studied

Type 2 Diabetes Mellitus (T2DM) — all drugs for Type 2 Diabetes Mellitus (T2DM) →

Sponsor

Universitas Noor Huda Mustofa

Who can join

Adults 40 to 70, any sex, with Type 2 Diabetes Mellitus (T2DM). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the effects of integrating spiritual care into the management of patients with type 2 diabetes mellitus. The study examines whether a structured spiritual care program can improve psychological resilience, reduce psychological distress, and help control blood glucose levels in adults with type 2 diabetes. Participants receive standard diabetes care, with one group also receiving spiritual care interventions delivered by trained health professionals. The findings of this study are expected to support a more holistic approach to diabetes management that addresses both physical and psychological well-being.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes Mellitus (T2DM)

Currently open trials in the same condition.

NCT07533539 — Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration · Phase 1 · recruiting
NCT07366775 — A Telenursing Program to Support Diabetes Self-Management · NA · active not recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07465224 — A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus · Phase 2 · recruiting
NCT07442006 — Glycemic Variability of Combination Therapies in T2DM · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07333625 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universitas Noor Huda Mustofa
Last refreshed: 12 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07333625.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing